 
								Lucigen/EZ-Tn5和贸易&书信电报;T7/KAN-2>;启动子插入试剂盒/EZI03T7/10反应
								
								
										市场价:
										¥10800.00
									
									
										美元价:
										6480.00
									
								
										产品分类:
										转染试剂
									
									
										公司分类:
										Transfection
									
								
										联系Q Q:
										3392242852
									
									
										电话号码:
										4000-520-616
									
								
										电子邮箱:
										info@ebiomall.com
									
									商品介绍
						RandominsertionofT7promotertodrivegeneexpressionwithT7RNApolymerase
- InsertT7promoterrandomlyintoanyDNAsequenceinvitro 
- IsolatepositivecloneswiththeselectablekanamycinMarker
- Expressresultingproductsinvivoorinvitro
- MinimizeinsertionbiaswiththehyperactiveTn5system,knownforhighestlevelofrandomness
Applications
- RandominsertionofasingleT7RNAPolymerasepromotertosynthesizeRNAfromanyregionofclonedDNA.
TheEZ-Tn5™<T7/KAN-2>PromoterInsertionKit*providesaneasyandreliablemethodtorandomlyinsertatransposoncontainingaphageT7RNApolymerasepromoterintoanyDNAmoleculeinvitro.Thetransposonendhasnoterminationsequences,soRNAcanbeproducedfromchoseninsertionclonesbyinvitrotranscriptionfromtheT7RNApolymerasepromoterusing,forexample,anyofEpicentre'sT7RNAPolymeraseTranscriptionKits.RNAcanalsobegeneratedforinvivoexpressionstudiesincellshavinganinducIBLeT7RNApolymerasegene.
|  | Figure1(clicktoenlarge).RNAtranscriptscanbeproducedfrominsertionclonesinvitroorinvivousingtheEZ-Tn5™<T7/KAN-2>PromoterInsertionKit. | 
*Coveredbyissuedand/orpendingpatents,exclusivelylicensedorassignedtoEpicentre®(anIllumina®Company).
ORDERINFORMATION
Contents:EZ-Tn5™Transposase,EZ-Tn5™Transposon,EZ-Tn5™10XReactionBuffer,EZ-Tn5™10XStopSolution,ForwardandReversePrimers,ControlTargetDNA,SterileWater品牌介绍
						美国Lucigen公司,自1998年成立至今,一直致力于生命科学领域相关科研产品的研究与开发,在分子生物学领域处于领导性地位。Lucigen公司主要开发各类用于基因克隆的试剂盒及相关产品,包括:CloneSmart®平端克隆试剂盒、BigEasy®线性克隆系统、pEZSeq™平端克隆试剂盒、ClonePlex™ AK文库构建试剂盒、DNA Terminator ®末端修复试剂盒、EconoTaq® DNA聚合酶及E.cloni感受态细胞等。Lucigen公司凭借其独到的产品技术,过硬的产品质量,良好的产品服务赢得了全球广大用户的信赖。
					
 
		
